Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Transcode Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
Revenues0.00.00.00.2
            Revenue growth  -100.0% 
Cost of goods sold0.00.00.00.5
Gross profit0.00.00.0-0.2
            Gross margin   -100.0%
Research and development10.22.80.3 
General and administrative8.43.40.40.2
EBIT-18.7-6.2-0.7-0.5
            EBIT margin   -201.9%
Pre-tax income-17.6-6.8-2.3-0.6
Income taxes0.00.10.00.0
            Tax rate0.0% 0.0%0.0%
Net income-17.6-6.8-2.3-0.6
            Net margin   -268.3%
 
Diluted EPS($1.35)($0.81)($0.51)($0.13)
Shares outstanding (diluted)13.08.44.64.6
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy